Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies
Topics: AIDS, HIV & STDs, Molecular Assays, General In Vitro Diagnostics, Infectious Diseases
Regions: Japan, United States, Europe
|
Pipeline Insight: HIV - The Age of Convenience
Topics: AIDS, HIV & STDs, Drug Discovery
|
Infectious Diseases Drugs Markets
Topics: AIDS, HIV & STDs, Drug Discovery, Infectious Diseases
|
The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Topics: AIDS, HIV & STDs, Research & Development, Prescription Drugs, Drug Discovery, Infectious Diseases
Regions: Global
|
Infections Herpes Simplex Virus Infection Therapy Area Pipeline Report
Topics: AIDS, HIV & STDs
|
Infections AIDS HIV Therapy Area Pipeline Report
Topics: AIDS, HIV & STDs, Infectious Diseases
|
Disease and Therapy Review: HIV/AIDS
Topics: AIDS, HIV & STDs
|
Strategic Analysis of the Healthcare Industry in Zambia
Topics: AIDS, HIV & STDs, Country Overviews, Microbiology & Virology, General In Vitro Diagnostics, Infectious Diseases
Regions: Zambia
|
HIV Market Forecast
Topics: AIDS, HIV & STDs, Manufacturing, Packaging & Detailing, Prescription Drugs
|
Forecast Insight: HIV - Cross-Class Fixed Dose Combinations Drive Continued Growth
Topics: AIDS, HIV & STDs, Prescription Drugs
|
In Vitro Diagnostics Market Analysis 2009-2024
Topics: In Vitro Diagnostics, AIDS, HIV & STDs, Diabetes, Molecular Assays, Over-the-Counter, Point-of-Care, General In Vitro Diagnostics
|
Dealmaking and Industry Outlook: Antivirals
Topics: AIDS, HIV & STDs, Research & Development, Prescription Drugs, Biopharmaceuticals
|
European HIV/AIDS Therapeutics Markets
Topics: AIDS, HIV & STDs
Regions: Europe
|
HIV Therapy Patent Landscape 2009
Topics: AIDS, HIV & STDs
|
AIDS Therapy Area Pipeline Report
Topics: AIDS, HIV & STDs
|
Herpes Simplex Virus Infection Therapy Area Pipeline Report
Topics: AIDS, HIV & STDs
|
Protease Inhibitors: Innovation Drives Drug Pipeline
Topics: AIDS, HIV & STDs, Research & Development, Drug Discovery
|
Global HIV Market: An Analysis
Topics: AIDS, HIV & STDs
Regions: Global
|
The 2009 Report on Human Immunodeficiency Virus (HIV) Treatments: World Market Segmentation by City
Topics: AIDS, HIV & STDs
|
Study for Opportunities Assessment for Hepatitis B Therapeutics in Taiwan
Topics: AIDS, HIV & STDs, Microbiology & Virology
Regions: Taiwan
|
U.S. Rate of New HIV Cases, 2008
Topics: AIDS, HIV & STDs
Regions: United States
|
Worldwide Percentage of Adults Living with HIV, 1990-2006
Topics: AIDS, HIV & STDs
Regions: Global
|
New Types of HIV Drugs
Topics: AIDS, HIV & STDs
|
Worldwide Rate of New HIV Cases, 1990-2007
Topics: AIDS, HIV & STDs
Regions: Global
|
The 2009-2014 Outlook for Human Immunodeficiency Virus (HIV) Treatments in India
Topics: AIDS, HIV & STDs
|
The 2009-2014 Outlook for Human Immunodeficiency Virus (HIV) Treatments in Greater China
Topics: AIDS, HIV & STDs
Regions: China
|
The 2009-2014 Outlook for Human Immunodeficiency Virus (HIV) Treatments in Japan
Topics: AIDS, HIV & STDs
|
The 2009-2014 Outlook for Human Immunodeficiency Virus (HIV) Treatments in the United States
Topics: AIDS, HIV & STDs
|
Global Antivirals Market Analysis & Forecasts 2008-2023
Topics: AIDS, HIV & STDs, Hepatitis, Drug Discovery
Regions: Global
|
HIV/AIDS Testing
Topics: AIDS, HIV & STDs
Regions: Global
|
HIV: Markets for Diagnostics and Therapeutics
Topics: AIDS, HIV & STDs, Microbiology & Virology
Regions: Global
|
MarketVIEW: Chlamydia trachomatis vaccines
Topics: AIDS, HIV & STDs, Vaccines, Women's Health, Obstetrics/Gynecology
|
The 2009-2014 World Outlook for Human Immunodeficiency Virus (HIV) Treatments
Topics: AIDS, HIV & STDs
Regions: Global
|
Commercial Insight: Select herpes viruses and human papilloma virus - Non-biologic interventions for oral and genital herpes, cytomegalovirus infection, herpes zoster and genital warts
Topics: AIDS, HIV & STDs
|
Commercial Insight: HIV - The battle for market share is getting fiercer
Topics: AIDS, HIV & STDs
|
Disease INFOPACK: Chlamydia trachomatis
Topics: AIDS, HIV & STDs, Vaccines
|
U.S. Research ELISA Markets
Topics: In Vitro Diagnostics, AIDS, HIV & STDs, Allergy/Immunology
Regions: United States
|
HIV Vaccine Update: R&D Innovation Critical in the Wake of Recent Setbacks
Topics: AIDS, HIV & STDs, Vaccines
|
Pipeline Insight: HIV - Novel NNRTIs address crucial unmet need
Topics: AIDS, HIV & STDs, Drug Discovery
|
Stakeholder Insight: Hiv Therapy Dynamics
Topics: AIDS, HIV & STDs, Research & Development, Prescription Drugs, Drug Discovery
|
Chinese Markets for HIV Treatment Drugs
Topics: AIDS, HIV & STDs
Regions: China
|
Commercial Insight: HIV - Reshaping Treatment Paradigms
Topics: AIDS, HIV & STDs
|
The Global HIV/AIDS Market Outlook to 2012
Topics: In Vitro Diagnostics, AIDS, HIV & STDs, Prescription Drugs
Regions: Global
|
Stakeholder Opinions: Hepatocellular Carcinoma - Opportune indication for novel therapies
Topics: AIDS, HIV & STDs, Infectious Diseases, Oncology/Hematology
|
The Global Antivirals Market: R&D Pipelines, Market Analysis and Competitive Landscape
Topics: AIDS, HIV & STDs, Microbiology & Virology, Research & Development
|
Anti-Infectives: World Market, 2nd Edition, Vol III: Antivirals
Topics: AIDS, HIV & STDs, Pharmaceuticals, Infectious Diseases
Regions: Global
|
Updated CDC HIV Testing Guidelines to Shape Evolving Diagnostics Market
Topics: AIDS, HIV & STDs, Microbiology & Virology
|
Infectious Disease Diagnostics Markets in sub-Saharan Africa
Topics: AIDS, HIV & STDs, Molecular Assays, Drug Delivery, Infectious Diseases
Regions: Africa
|
Commercial Insight: HIV - Change of guard
Topics: AIDS, HIV & STDs, Research & Development
Regions: United States, Europe
|
Antivirals
Topics: AIDS, HIV & STDs, Hepatitis, Pharmaceuticals, Prescription Drugs, Infectious Diseases
Regions: Global
|
